OLEMA PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $284.6M | $13.8M |
| FY2022 | — | $197.5M | $23.7M |
| FY2023 | — | $253.9M | $68.5M |
| FY2024 | — | $409.0M | $139.5M |
| FY2025 | — | $478.6M | $48.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $284.6M | $13.8M |
| FY2022 | — | $197.5M | $23.7M |
| FY2023 | — | $253.9M | $68.5M |
| FY2024 | — | $409.0M | $139.5M |
| FY2025 | — | $478.6M | $48.3M |